KLYG (Kelyniam Global) Market Cap: $7.52 Mil (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kelyniam Global Market Cap?

Kelyniam Global KLYG +4.82% Market Cap is $7.52 Mil as of Jul. 28, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Kelyniam Global's share price for the quarter that ended in Mar. 2008 was $0. Kelyniam Global's Shares Outstanding (EOP) for the quarter that ended in Mar. 2008 was 19.52 Mil. Therefore, Kelyniam Global's market cap for the quarter that ended in Mar. 2008 was $0.00 Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kelyniam Global's Enterprise Value for Today is $7.52 Mil.


Kelyniam Global  (OTCPK:KLYG) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Kelyniam Global Market Cap Related Terms


Kelyniam Global Market Cap Historical Data

* Premium members only.

The historical data trend for Kelyniam Global's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kelyniam Global Market Cap Chart

Kelyniam Global Annual Data
Trend Dec06 Dec07
Market Cap
0.00 0.00

Kelyniam Global Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Market Cap Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

KLYG vs VASO, WCUI, MODD: Market Cap Comparison

For the Medical Devices subindustry, Kelyniam Global's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kelyniam Global Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kelyniam Global's Market Cap distribution charts can be found below:

* The bar in red indicates where Kelyniam Global's Market Cap falls into.



Kelyniam Global Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Kelyniam Global's Market Cap for the fiscal year that ended in Dec. 2007 is calculated as

Market Cap (A: Dec. 2007 )=Share Price (A: Dec. 2007 )*Shares Outstanding (EOP) (A: Dec. 2007 )
=$0*19.028
=$0.00

Kelyniam Global's Market Cap for the quarter that ended in Mar. 2008 is calculated as

Market Cap (Q: Mar. 2008 )=Share Price (Q: Mar. 2008 )*Shares Outstanding (EOP) (Q: Mar. 2008 )
=$0*19.523
=$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $7.52 Mil mean?
Kelyniam Global (KLYG) has a Market Cap of $7.52 Mil as of Jul. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kelyniam Global and its competitors.
Is Kelyniam Global's Market Cap too high?
Kelyniam Global's current Market Cap is $7.52 Mil. The Medical Devices & Instruments industry median Market Cap is 112.86. Kelyniam Global's value of $7.52 Mil is 93.3% below this industry median.
How does Kelyniam Global's Market Cap compare to VASO and WCUI?
Kelyniam Global's Market Cap of $7.52 Mil can be compared against companies in the Medical Devices & Instruments industry. The industry median Market Cap is 112.86. Kelyniam Global's value of $7.52 Mil is 93.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 112.86, based on 862 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kelyniam Global's current Market Cap of $7.52 Mil is 93.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kelyniam Global and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 112.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kelyniam Global's current Market Cap is $7.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelyniam Global stock overvalued right now?
Kelyniam Global (KLYG) has a current Market Cap of $7.52 Mil. The current Market Cap is $7.52 Mil and 93.3% below the Medical Devices & Instruments industry median of 112.86. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Kelyniam Global (KLYG), the current Market Cap is $7.52 Mil as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kelyniam Global Business Description

Address 97 River Road, Suite A, Canton, CT, USA, 06019
Kelyniam Global Inc specializes in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer aided manufacturing of developed medical grade polymers. The Company develops, manufactures, and distributes custom cranial and maxilla-facial implants for patients requiring the reconstruction of cranial and certain facial structures. The Company's business operations consist of regulatory approvals, manufacturing operations and distribution to customers and markets in the United States.